Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1.

McElroy AK, Shrivastava-Ranjan P, Harmon JR, Martines RB, Silva-Flannery L, Flietstra TD, Kraft CS, Mehta AK, Lyon GM, Varkey JB, Ribner BS, Nichol ST, Zaki SR, Spiropoulou CF.

Emerg Infect Dis. 2019 Feb;25(2):290-298. doi: 10.3201/eid2502.181326.

2.

Ebola Infection in Pregnancy: A Global Perspective and Lessons Learned.

Haddad LB, Horton J, Ribner BS, Jamieson DJ.

Clin Obstet Gynecol. 2018 Mar;61(1):186-196. doi: 10.1097/GRF.0000000000000332. Review.

3.

Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.

Raabe VN, Kann G, Ribner BS, Morales A, Varkey JB, Mehta AK, Lyon GM, Vanairsdale S, Faber K, Becker S, Eickmann M, Strecker T, Brown S, Patel K, De Leuw P, Schuettfort G, Stephan C, Rabenau H, Klena JD, Rollin PE, McElroy A, Ströher U, Nichol S, Kraft CS, Wolf T; Emory Serious Communicable Diseases Unit.

Clin Infect Dis. 2017 Sep 1;65(5):855-859. doi: 10.1093/cid/cix406.

4.

A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.

McElroy AK, Akondy RS, Harmon JR, Ellebedy AH, Cannon D, Klena JD, Sidney J, Sette A, Mehta AK, Kraft CS, Lyon MG, Varkey JB, Ribner BS, Nichol ST, Spiropoulou CF.

J Infect Dis. 2017 Jun 15;215(12):1862-1872. doi: 10.1093/infdis/jix201.

5.

The National Ebola Training and Education Center: Preparing the United States for Ebola and Other Special Pathogens.

Kratochvil CJ, Evans L, Ribner BS, Lowe JJ, Harvey MC, Hunt RC, Tumpey AJ, Fagan RP, Schwedhelm MM, Bell S, Maher J, Kraft CS, Cagliuso NV Sr, Vanairsdale S, Vasa A, Smith PW.

Health Secur. 2017 May/Jun;15(3):253-260. doi: 10.1089/hs.2017.0005.

PMID:
28636442
6.

Clinical Management of Patients with Ebola Virus Disease in High-Resource Settings.

Marshall Lyon G, Mehta AK, Ribner BS.

Curr Top Microbiol Immunol. 2017;411:115-137. doi: 10.1007/82_2017_19.

PMID:
28601946
7.

Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor.

Shantha JG, Crozier I, Varkey JB, Kraft CS, Lyon GM 3rd, Mehta AK, Carlson RD, Hill CE, Kumar G, Debiec MR, Patel PS, Olsen TW, Nussenblatt RB, Martin DF, Ströher U, Uyeki TM, Ribner BS, Smith JR, Yeh S.

Ophthalmology. 2016 Dec;123(12):2626-2628.e2. doi: 10.1016/j.ophtha.2016.07.013. Epub 2016 Sep 1. No abstract available.

8.

Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease.

McElroy AK, Harmon JR, Flietstra TD, Campbell S, Mehta AK, Kraft CS, Lyon MG, Varkey JB, Ribner BS, Kratochvil CJ, Iwen PC, Smith PW, Ahmed R, Nichol ST, Spiropoulou CF.

Clin Infect Dis. 2016 Aug 15;63(4):460-7. doi: 10.1093/cid/ciw334. Epub 2016 Jun 27.

9.

Preparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught Us.

Varkey JB, Ribner BS.

Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.EI10-0011-2016.

10.

Ebola Virus Persistence in Semen of Male Survivors.

Uyeki TM, Erickson BR, Brown S, McElroy AK, Cannon D, Gibbons A, Sealy T, Kainulainen MH, Schuh AJ, Kraft CS, Mehta AK, Lyon GM 3rd, Varkey JB, Ribner BS, Ellison RT 3rd, Carmody E, Nau GJ, Spiropoulou C, Nichol ST, Ströher U.

Clin Infect Dis. 2016 Jun 15;62(12):1552-1555. doi: 10.1093/cid/ciw202. Epub 2016 Apr 3.

PMID:
27045122
11.

Ebola Virus Disease: Experience and Decision Making for the First Patients outside of Africa.

Stephens DS, Ribner BS, Gartland BD, Feistritzer NR, Farley MM, Larsen CP, Fox JT.

PLoS Med. 2015 Jul 28;12(7):e1001857. doi: 10.1371/journal.pmed.1001857. eCollection 2015 Jul.

12.

Comparison of FilmArray and Quantitative Real-Time Reverse Transcriptase PCR for Detection of Zaire Ebolavirus from Contrived and Clinical Specimens.

Southern TR, Racsa LD, Albariño CG, Fey PD, Hinrichs SH, Murphy CN, Herrera VL, Sambol AR, Hill CE, Ryan EL, Kraft CS, Campbell S, Sealy TK, Schuh A, Ritchie JC, Lyon GM 3rd, Mehta AK, Varkey JB, Ribner BS, Brantly KP, Ströher U, Iwen PC, Burd EM.

J Clin Microbiol. 2015 Sep;53(9):2956-60. doi: 10.1128/JCM.01317-15. Epub 2015 Jul 8.

13.

Ebola virus disease: preparedness and infection control lessons learned from two biocontainment units.

Hewlett AL, Varkey JB, Smith PW, Ribner BS.

Curr Opin Infect Dis. 2015 Aug;28(4):343-8. doi: 10.1097/QCO.0000000000000176. Review.

14.

Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States.

Liddell AM, Davey RT Jr, Mehta AK, Varkey JB, Kraft CS, Tseggay GK, Badidi O, Faust AC, Brown KV, Suffredini AF, Barrett K, Wolcott MJ, Marconi VC, Lyon GM 3rd, Weinstein GL, Weinmeister K, Sutton S, Hazbun M, Albariño CG, Reed Z, Cannon D, Ströher U, Feldman M, Ribner BS, Lane HC, Fauci AS, Uyeki TM.

Ann Intern Med. 2015 Jul 21;163(2):81-90. doi: 10.7326/M15-0530.

15.

Persistence of Ebola Virus in Ocular Fluid during Convalescence.

Varkey JB, Shantha JG, Crozier I, Kraft CS, Lyon GM, Mehta AK, Kumar G, Smith JR, Kainulainen MH, Whitmer S, Ströher U, Uyeki TM, Ribner BS, Yeh S.

N Engl J Med. 2015 Jun 18;372(25):2423-7. doi: 10.1056/NEJMoa1500306. Epub 2015 May 7. Erratum in: N Engl J Med. 2015 Jun 18;372(25):2469.

16.

Environmental infection control considerations for Ebola.

Lowe JJ, Olinger PL, Gibbs SG, Rengarajan K, Beam EL, Boulter KC, Schwedhelm MM, Hayes AK, Kratochvil CJ, Vanairsdale S, Frislie B, Lewis J, Hewlett AL, Smith PW, Gartland B, Ribner BS.

Am J Infect Control. 2015 Jul 1;43(7):747-9. doi: 10.1016/j.ajic.2015.03.006. Epub 2015 Apr 29. No abstract available.

PMID:
25934067
17.

The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States.

Kraft CS, Hewlett AL, Koepsell S, Winkler AM, Kratochvil CJ, Larson L, Varkey JB, Mehta AK, Lyon GM 3rd, Friedman-Moraco RJ, Marconi VC, Hill CE, Sullivan JN, Johnson DW, Lisco SJ, Mulligan MJ, Uyeki TM, McElroy AK, Sealy T, Campbell S, Spiropoulou C, Ströher U, Crozier I, Sacra R, Connor MJ Jr, Sueblinvong V, Franch HA, Smith PW, Ribner BS; Nebraska Biocontainment Unit and the Emory Serious Communicable Diseases Unit.

Clin Infect Dis. 2015 Aug 15;61(4):496-502. doi: 10.1093/cid/civ334. Epub 2015 Apr 22.

18.

Human Ebola virus infection results in substantial immune activation.

McElroy AK, Akondy RS, Davis CW, Ellebedy AH, Mehta AK, Kraft CS, Lyon GM, Ribner BS, Varkey J, Sidney J, Sette A, Campbell S, Ströher U, Damon I, Nichol ST, Spiropoulou CF, Ahmed R.

Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):4719-24. doi: 10.1073/pnas.1502619112. Epub 2015 Mar 9.

19.

Performance of bedside diagnostic ultrasound in an Ebola isolation unit: the Emory University Hospital experience.

Moreno CC, Kraft CS, Vanairsdale S, Kandiah P, Klopman MA, Ribner BS, Tridandapani S.

AJR Am J Roentgenol. 2015 Jun;204(6):1157-9. doi: 10.2214/AJR.15.14344. Epub 2015 Mar 2.

20.

Successful delivery of RRT in Ebola virus disease.

Connor MJ Jr, Kraft C, Mehta AK, Varkey JB, Lyon GM, Crozier I, Ströher U, Ribner BS, Franch HA.

J Am Soc Nephrol. 2015 Jan;26(1):31-7. doi: 10.1681/ASN.2014111057. Epub 2014 Nov 14.

Supplemental Content

Loading ...
Support Center